Health Ministry registers AstraZeneca-SKBio vaccine for emergency use
The Ukrainian Ministry of Health registered the Korean-made AstraZeneca-SKBio vaccine against COVID-19 for emergency medical use on April 20, the ministry said on Facebook on Wednesday.
According to the report, AstraZeneca-SKBio is developed by the University of Oxford and the British-Swedish company AstraZeneca. It is produced in the Republic of Korea (SK Bioscience Co. Ltd) and has the trade name AstraZeneca-SKBio. An emergency vaccine has already been approved by the World Health Organization (WHO). The UK, the European Union, India and Canada have also given permission to use it.
Advertising
Advertising
MORE ABOUT
Vaccination with AstraZeneca-SKBio to begin in most regions on Wednesday – Liashko
15:36, 23.04.2021
Ukraine receives 2nd batch of coronavirus vaccine, over 367,000 doses - Health Ministry
10:10, 23.04.2021
LATEST
Ukrainian govt dismisses three dpty ministers of development of communities, territories, infrastructure
20:56, 17.05.2024
Already three killed, 28 injured reported in Kharkiv
20:46, 17.05.2024
In Vovchansk, as result of enemy shelling, one person killed, one wounde
20:45, 17.05.2024
EBA, following SUP, criticizes Arakhamia's bill No. 11195 on implementation of sanctions supported by Ministry of Justice with amendments
20:37, 17.05.2024
Over 700,000 subscribers of Home Internet service can use it for about four hours after power outage